-
In the therapeutical equipment of the few drugs capable to fight age-related macular degeneration, the inhibitors of vascular endothelial growth factor, bevacizumab and ranibizumab, have recently been added. The first one has been approved by FDA in the treatment of cancer, while in the indication [...]
-
It is not rare the case of patients presenting a sudden sight loss in an area of the visual filed and in some cases the examinations they performed reveal a cerebrovascular problem. Researchers have wondered whether it is possible to identify these problems with a simple clinical examination before [...]
-
The problem of multifocal glasses is that the vision of objects on the floor must be made through the lower segment of the lens and it can imply an alteration in the perception of deepness, which probably explains the fact that older adults with multifocal glasses are at a high risk of falls. In a [...]
-
In 1996, the U. S. Preventive Services Task Force (USPSTF) advised visual screening in subjects over 65, with a level B recommendation, on the basis that vision measurement is a cheap procedure, which has no risks. In 2009, guidelines relative to this practice have been updated, and there has been [...]
-
The relaxation of smooth muscles obtained with tamsulosin in the bladder neck and prostate can also be found in the iris and it can cause the floppy iris syndrome and can be an additional difficulty during cataract surgery. To evaluate the possible additional risks on this occasion, some Canadian [...]
-
In the WAFACS (Women's Antioxidant and Folic Acid Cardiovascular Study) trial, more than 5400 women with known heart diseases or with cardiovascular risk factors have been randomized to receive placebo or a combination of vitamins B (folic acid, vitamin B6 and B12). The supplementation neither [...]
-
According to some trials, it results that the use of rennin-angiotensin system inhibitors is capable to decrease the incidence and the evolution of diabetic retinopathy in patients affected by type 1 diabetes. With a trial sponsored by pharmaceutical industry, 3810 adults affected by [...]
-
In patients affected by age-related macular degeneration, neovascularization is reliable for severe losses of sight, so a theoretically effective approach is made of therapies able to inhibit endothelial growth factor. In two studies sponsored by pharmaceutical industry were examined the effects of [...]
-
To verify whether there is an association between two particularly frequent conditions in old age, macular degeneration and stroke, a prospective trial on 10.405 patients of both sexes (45 to 64 years of age) not affected by cardiovascular diseases and having a retinal photographic documentation. [...]